个人简介

Mark is the Head of Pharmacy Discipline. Mark's career in pharmacy includes: academic, locum, managing, and consultant pharmacist in Tasmania, Northern Territory, and the Australian Capital Territory. Mark has international research experience and was a post-doctoral fellow at the University of Groningen, The Netherlands. Mark has held/holds several medication review contracts with Aged Care Facilities in the NT and ACT. Mark is a member of the editorial board for Journal of Clinical Pharmacy and Therapeutics, a leading international journal in pharmacy and clinical pharmacology. Mark is an assessor for the Australian Research Council and reviewer, inter alia, for the Australian Medicines Handbook and Australian Pharmaceutical Formulary and Handbook.

研究领域

Applied Therapeutics Research Planning Research Project Pharmacy Practice Quality Use of Medicines Pharmaceutics (dispensing)

Clinical Pharmacy Aged Care Drug Utilization and Medication Safety Pharmacoeconomics Pharmacoepidemiology Health Literacy Pharmacy Education Medication Adherence Infectious Diseases Therapeutic Drug Monitoring

近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Mutie M, Cooper G, Kyle G, Naunton M, Zwar N. Travelling with medications and medical equipment across international borders. Travel Medicine and Infectious Disease 2014 (in press) Naunton M, Kyle GJ, Owoka F, Naunton-Boom K. Pharmacist review prevents evolving metformin-associated lactic acidosis. J Clin Pharm Ther. 2014;Early View (online). DoI 10.1111/jcpt.12187 Mutie M, Naunton M, Cooper G, Kyle G, Zwar N. Role of pharmacists in collaborative care of travellers with chronic conditions. Travel Med Infect Dis. 2014 May-Jun;12(3):286-7 Waddington F, Naunton M, Kyle G. Statins: a Catalyst for non-adherence. Aust Pharm 2014; 33(3):62-6 Mutie M, Cooper GM, Kyle G, Naunton M. A travel health service road map for pharmacists. Aust Pharm 2014;33(3):68-71 Peterson, G. M., & Naunton, M. (2014). Re: Children living near fast food outlets in England are more likely to be overweight, study shows. BMJ 2014;348:g1557. Naunton M. Statin-induced myopathy: Innocent until proven otherwise? Aust Pharm 2013; 32(11):66-71 Naunton M, Goldberg I. Glaucoma: Management is in the eye of the beholder. Aust Pharm 2013; 32(9):66-69 Deeks L, Naunton M, Currie MJ, Bowden FJ. Topical ivermectin 0.5% for treatment of head lice. Ann Pharmacother. 2013 Sep;47(9):1161-7 McDerby N, Kyle G, Naunton M. Safe to crush? A pilot study into solid dosage form modification in aged care. Australasian Journal on Ageing 2013 (in press). DOI: 10.1111/ajag.12037 Sutcliff E, Naunton M, Kyle G. Managing Gout. Aust Pharm 2013; 32(1):62-7 Naunton M, Merrilees L. Evidence in patient care: Venous thromboembolism prophylaxis. Aust Pharm 2012; 31(5) :392-96 Deeks L, Cooper G, Naunton M. Public health screening in the pharmacy: a focus on chlamydia. Aust Pharm 2012; 31(3):210-16. De Zylva JB, Naunton M, Szabo F, Dettwiller P. Adherence to Prophylaxis Guidelines in Patients that Develop Symptomatic Venous Thromboembolism. J Pharm Pract Res 2012; 42(1):37-42. Naunton M. Post-hospital Discharge Home Medication Review: Proof of Concept (n=1). Aust Pharm 2011; 30(12):1026-32. Naunton M. The Easter bunny and the chocolate conspiracy. Med J Aust 2011; 194(12):672 Peterson GM, Naunton M. Safety of Ibuprofen vs. paracetamol. Br J Clin Pharmacol 2011;71(6):964 Duyvendak M, Naunton M, van Roon EN, Brouwers JRBJ. Doctors' beliefs and knowledge on corticosteroid-induced osteoporosis: identifying barriers to improve prevention. J Clin Pharm Ther. 2011 Jun;36(3):356-66 Peterson GM, Naunton M, Tichelaar LK, Gennari L. Lasofoxifene: Selective Estrogen Receptor Modulator for the Prevention and Treatment of Postmenopausal Osteoporosis. Ann Pharmacother 2011 Apr;45(4):499-509 Peterson GM, Tan SI, Jackson SL, Naunton M. Violence in community pharmacy in Australia: incidence and implications. Int J Clin Pharm. 2011 Apr;33(2):264-72